The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.
about
Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.Current and novel immunosuppressive therapy for autoimmune hepatitis.Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristicsRelationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese.Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome.Diffuse systemic sclerosis and autoimmune hepatitis: a unique association.Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction.Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type.Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women.Autoimmune hepatitis: an evolving demography?Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype.Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
P2860
Q34429256-55C28B87-6AB6-4F34-9CB2-D9A653ED6DA2Q34490185-DBAD734F-4FD2-45DF-8614-62801F4072FFQ35594867-FC105D14-7336-4468-8ECE-223A91756F37Q36415651-93740BCC-6AEB-4A5A-9EB3-A5AF92BCD3DBQ37099395-D7E2050D-5601-45DA-AE9A-93A325F5F8E1Q37688954-2381D625-70EB-48BF-8EE0-A9ED152F0EA1Q39035303-47BC3B08-A19C-4407-9164-2335BAEE61B1Q39436336-6177F6CF-EDDF-43D1-BDAF-86CC7AC9FD10Q39909023-E95B6AF6-C3E7-4F36-B154-EE4A455613FCQ40531417-246FCA7E-5CA9-4841-B9C5-7AECA284245DQ43860532-27DF257B-22B1-42D1-A0C1-04CFE993F7D4Q45711310-F03FC017-2A30-4CBA-923B-17D9CD5AD39EQ46196074-0D77E806-BF95-4ED4-902C-BF6F4E8E7A02Q51031338-CAE334A0-54ED-4204-9F43-82C162273811Q55442256-784839FB-9516-4C04-87DE-0EBD58519FD5
P2860
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The relationship between autoi ...... romes in autoimmune hepatitis.
@ast
The relationship between autoi ...... romes in autoimmune hepatitis.
@en
type
label
The relationship between autoi ...... romes in autoimmune hepatitis.
@ast
The relationship between autoi ...... romes in autoimmune hepatitis.
@en
prefLabel
The relationship between autoi ...... romes in autoimmune hepatitis.
@ast
The relationship between autoi ...... romes in autoimmune hepatitis.
@en
P2860
P356
P1433
P1476
The relationship between autoi ...... romes in autoimmune hepatitis.
@en
P2093
McFarlane IG
P2860
P304
P356
10.1136/GUT.42.5.599
P407
P577
1998-05-01T00:00:00Z